1. Home
  2. MTA vs MRVI Comparison

MTA vs MRVI Comparison

Compare MTA & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metalla Royalty & Streaming Ltd.

MTA

Metalla Royalty & Streaming Ltd.

HOLD

Current Price

$7.75

Market Cap

636.3M

Sector

N/A

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$5.16

Market Cap

559.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTA
MRVI
Founded
1983
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
636.3M
559.0M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
MTA
MRVI
Price
$7.75
$5.16
Analyst Decision
Hold
Buy
Analyst Count
1
4
Target Price
$9.00
$4.13
AVG Volume (30 Days)
486.5K
3.0M
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
N/A
$185,743,000.00
Revenue This Year
$81.63
$12.54
Revenue Next Year
$62.44
$7.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.44
$1.99
52 Week High
$9.25
$5.00

Technical Indicators

Market Signals
Indicator
MTA
MRVI
Relative Strength Index (RSI) 59.79 71.36
Support Level $7.56 $3.27
Resistance Level $7.74 N/A
Average True Range (ATR) 0.35 0.23
MACD 0.08 0.03
Stochastic Oscillator 82.66 86.78

Price Performance

Historical Comparison
MTA
MRVI

About MTA Metalla Royalty & Streaming Ltd.

Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company that engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests. Geographically, the company generates revenue from Australia, Brazil, Mexico, and the USA, with the majority generated from Brazil.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: